InflaRx

IFRXNasdaq Germany Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$133.019 M

$1.84 +6.98%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

72,292,859

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#291TuHURA BiosciencesHURA$135.6M
#292EquilliumEQ$133.4M
#293InflaRxIFRX$133.0M
#294ProMIS NeurosciencesPMN$131.9M
#295NRX PharmaceuticalsNRXP$129.7M

Where these numbers come from

Share counts and financials for InflaRx are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.